Hanson Wade's 9th Annual Clinicial Biomarkers & World CDx summit was the hub for the biomarker, translational and diagnostic community to advance the translation from exploratory biomarker into clinically validated signature and ultimately a proven, predictive IVD.
We are very proud and excited to have hosted Dr Robyn Sussman, University of Pennslyvania, who presented a talk on October 5th at 12:30pm; "Kicking the tires before driving off to clinical validation: using reference standards to define performance characteristics of new NGS assays".
Dr Sussman leads the Center for Personalized Diagnostics Research and Development team, which develops and validates new clinical assays for use at the CPD. Dr. Sussman received her PhD in Cell and Developmental Biology from Thomas Jefferson University. She then completed her postdoctoral training at the Children’s Hospital of Philadelphia.
We hope that you had a chance to join us at our stand, if you did miss us, please get in touch with us below to find out more about Dr Sussman's talk, and what we can offer you.
To learn more about our Reference Standards, click here.